Related Experiment Videos
Cost-of-illness studies.
1College of Pharmacy, Pain Management Outcomes and Pharmacoeconomics Research Center, University of Utah Health Sciences Center, USA. goderda@pharm.utah.edu
Journal of Pain & Palliative Care Pharmacotherapy
|December 3, 2003
Summary
Cost-of-illness studies assess a disease's societal economic impact, guiding public health priorities and treatment evaluations. Including direct and indirect costs from a societal perspective is crucial, though international comparisons face challenges.
Area of Science:
- Health Economics
- Public Health Policy
Background:
- Cost-of-illness (COI) studies are vital for understanding the economic burden of diseases.
- These studies inform resource allocation and the economic evaluation of interventions.
- A societal perspective, encompassing direct and indirect costs, is essential for comprehensive analysis.
Purpose of the Study:
- To highlight the importance of cost-of-illness studies in public health and economic evaluations.
- To emphasize the inclusion of both direct and indirect costs from a societal viewpoint.
- To identify challenges in comparing COI studies across different countries.
Main Methods:
- Review of methodologies for cost-of-illness studies.
- Emphasis on adopting a societal perspective.
- Inclusion of direct medical and non-medical costs, and indirect costs (e.g., productivity losses).
Main Results:
- Indirect costs frequently surpass direct costs in disease burden.
- Societal perspective provides a more complete economic impact assessment.
- International comparisons of COI studies are complicated by numerous factors.
Conclusions:
- Cost-of-illness studies are indispensable tools for health policy and economic decision-making.
- Standardized methodologies and a societal perspective enhance study comparability.
- Acknowledging cross-country differences is critical for accurate interpretation of global disease economic impacts.